Target intelligence / Profile preview

Long intergenic non-protein coding RNA 2864 (LINC02864)

Target: LINC02864
Molecular classification: Other (Long non-coding RNA, lncRNA)

Overview

Long intergenic non-protein coding RNA 2864 (LINC02864) is a human long non-coding RNA (lncRNA) gene, also known by the alias RP11-169F17.1. It does not encode a protein but acts at the RNA level to regulate cellular functions. LINC02864 is differentially expressed in several cancers, most notably high-grade serous ovarian cancer (HGSOC), where it is downregulated in the \"differentiated\" subtype and upregulated in the \"immunoreactive\" subtype, suggesting a role in immune regulation and cancer biology[2]. It is also described in head and neck cancer and gastric cancer, potentially interacting with multiple microRNAs (for example, miR-3155a, miR-3678-3p, miR-875-3p, among others), but the direct molecular mechanism is not well characterized[2]. There is no evidence that LINC02864 encodes a receptor, enzyme, transporter, or is a direct therapeutic target, nor are there drugs known to modulate its function. Its significant differential expression in cancer subtypes may make it a candidate for further biomarker development.

Other names: RP11-169F17.1LINC02864

Biological functions

Regulation of gene expression (likely by acting as a competing endogenous RNA or via miRNA interaction)Immune modulation (putative, based on immune subtype specificity)Potential involvement in cell proliferation and differentiation

Disease associations

Cancer (notably high-grade serous ovarian cancer, head and neck cancer, gastric cancer)Other (given links to cell differentiation and immune regulation, may be implicated in other pathologies, but specific evidence is limited)

Beyond the preview

Go deeper on Long intergenic non-protein coding RNA 2864 (LINC02864).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Long intergenic non-protein coding RNA 2864 (LINC02864).

Explore the full profile